Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
February 11, 2021
Ensoma Announces Strategic Collaboration with Takeda to Accelerate Next-Generation In Vivo Gene Therapies
February 11, 2021
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines
February 10, 2021
Impel NeuroPharma Partners With Veeva Systems to Build Integrated, Digital-First Commercial Foundation
February 10, 2021
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
February 8, 2021
IDEAYA Announces IDE397 IND Clearance by U.S. FDA to Initiate Phase 1 and Appointment of Matthew Maurer, M.D., as Vice President, Head of Clinical Oncology and Medical Affairs
February 8, 2021
Homology Medicines Announces First Presentation of Data with HMI-203 In Vivo Gene Therapy Development Candidate for Hunter Syndrome
February 5, 2021
Vor Biopharma Announces Pricing of Initial Public Offering
February 4, 2021
Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase I Study
February 3, 2021
TMRW Launches World’s First Automated Platform to Safeguard Millions of Frozen Eggs and Embryos Used in IVF
February 3, 2021
Crinetics Pharmaceuticals Advances CRN04777 For Congenital Hyperinsulinism into Phase 1 Study
« Previous Page
1
…
28
29
30
31
32
…
103